Cadila Healthcare rose 2.60% to Rs 646.10 after the company s subsidiary announced plans to sell its India focused animal health business to Multiples Alternate Asset Management led consortium.
Zydus Animal Health and Investments (ZAHL), a wholly owned material subsidiary of Cadila Healthcare, has entered into a business transfer agreement (BTA) and other ancillary agreements to sell and transfer its Animal Healthcare Established Markets Undertaking (Zydus AH) to Multiples Alternate Asset Management led consortium.
The deal is to sell one of the two business undertakings of ZAHL, called Animal Healthcare Established Markets Undertaking on a slump sale basis as a going concern, for a lump sum consideration of Rs 2,921 crore on a cash free and debt free basis, subject to certain closing date adjustments and other conditions.
Cadila Healthcare Ltd (Zydus Cadila) s wholly-owned material subsidiary Zydus Animal Health and Investments Limited (ZAHL) is set to sell its animal healthcare business to a consortium led by Multiples Alternate Asset Management for nearly Rs 3,000 crore.
Zydus Cadila on Wednesday announced that ZAHL has entered into a business transfer agreement (BTA) and other ancillary agreements to sell and transfer Zydus AH, its animal healthcare established markets undertaking to the Multiples-led consortium. The deal is to sell one of the two business undertakings of ZAHL on a slump sale basis as a going concern, for a lump sum consideration of Rs 2,921 crore on a cash-free and debt-free basis, subject to certain closing date adjustments and other conditions. The transaction involves transfer of immovable assets, movable assets, inventory, brands and intangible assets, contracts, licenses and permissions, business records, employees along with employee benefit funds, insurance policies, ot
Cadila Healthcare share hits 52-week high as firm to sell animal health business
The consortium, including Canada Pension Plan Investment Board and Rakesh Jhunjhunwala-backed RARE Enterprises, has agreed to purchase the Undertaking through an SPV controlled by them, in the name of Zenex Animal Health India Private Limited for Rs 2,921 crore
BusinessToday.In | May 12, 2021 | Updated 18:06 IST
Representative Image
Share of Cadila Healthcare rose nearly 7 per cent to hit a 52-week high after the company announced that Zydus Animal Health and Investments Limited (ZAHL), a wholly-owned material subsidiary of Cadila Healthcare Limited, has entered into a Business Transfer Agreement (BTA) and other ancillary agreements to sell and transfer its Animal Healthcare Established Markets Undertaking to Multiples Alternate Asset Management led consortium.
Multiples, CPPIB and Jhunjhunwala’s RARE to buy Cadila’s Animal Health biz for Rs 2921 crores
SECTIONS
Multiples, CPPIB and Jhunjhunwala’s RARE to buy Cadila’s Animal Health biz for Rs 2921 croresET Bureau
Last Updated: May 12, 2021, 12:06 PM IST
Share
Synopsis
The consortium, through an SPV controlled by them, has signed a definitive agreement to acquire Animal Healthcare Established Markets Undertaking focused on India and certain other countries, the company said in a statement.
Zydus AH is the second largest and one of the fastest growing animal health businesses in India.
The consortium, through an SPV controlled by them, has signed a definitive agreement to acquire Animal Healthcare Established Markets Undertaking focused on India and certain other countries, the company said in a statement.